Papers

5

Total Citations

29

H-Index

3

About

Yarah M. Haidar is a leading surgical oncologist whose research centers on human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) and the refinement of surgical approaches, particularly transoral robotic surgery (TORS). Her major contributions include redefining risk stratification for contralateral cervical nodal disease in early-stage HPV+ OPSCC, challenging traditional treatment paradigms to minimize overtreatment while preserving oncologic safety. Her 2021 paper on this topic has garnered 14 citations, underscoring its clinical impact. Haidar has also advanced the management of cancer of unknown primary (CUP), demonstrating through national database analyses that TORS improves survival outcomes in HPV+ cases. Her work on treatment delays and HPV status, published in 2024, provides critical insights into how timing affects prognosis in patients undergoing upfront surgery. Additionally, she has explored robotic-assisted neck dissection, pushing the boundaries of minimally invasive techniques. With a growing citation record and a focus on evidence-based, de-escalation strategies, Haidar is shaping the future of head and neck cancer care, offering students and researchers a model of how translational research directly informs surgical practice.

Research Focus

Key Achievements

3
H-Index
5
Papers
29
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era
14 citations · 2021
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Icahn School of Medicine at Mount Sinai, University of California, Irvine

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago